Weidong Zhu - Publications

Origins of biallelic inactivation of NF2 in neurofibromatosis type 2.

Journal: Neuro-oncology

Published: December 17, 2021

Age-dependent copy number variations of TP53 tumour suppressor gene associated with altered phosphorylation status of p53 protein in sporadic schwannomas.

Journal: Journal of neuro-oncology

Published: February 23, 2019

EYA1 mutations leads to Branchio-Oto syndrome in two Chinese Han deaf families.

Journal: International journal of pediatric otorhinolaryngology

Published: December 27, 2018

Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.

Journal: EBioMedicine

Published: August 08, 2018

Intratympanic Gentamicin for Small Vestibular Schwannomas With Intractable Vertigo.

Journal: Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology

Published: July 19, 2018

Impact of cochlear implantation on the management strategy of patients with neurofibromatosis type 2.

Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery

Published: March 22, 2018

Long-Term Hearing Preservation Outcomes for Small Vestibular Schwannomas: Retrosigmoid Removal Versus Observation.

Journal: Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology

Published: January 10, 2018

Genetic and epigenetic patterns in patients with the head-and-neck paragangliomas associate with differential clinical characteristics.

Journal: Journal of cancer research and clinical oncology

Published: January 04, 2017

p53 performs an essential role in mediating the oncogenic stimulus triggered by loss of expression of neurofibromatosis type 2 during in vitro tumor progression.

Journal: Oncology letters

Published: September 15, 2015